![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
20
Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Losartan potassium, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2012-209 - Rev 00
This Chemical Type CEP, issued on December 17, 2013, remains in force until June 14, 2019, ensuring its reliability within the pharmaceutical industry.
Substance Number 2232 associated with this CEP further emphasizes